1 / 46

Drugs that affect the Urinary System

Drugs that affect the Urinary System. NURS 1950: Pharmacology. Diuretics work in the kidney at various sites of the nephron Can interfere with the action of aldosterone causing loss of sodium Where goes sodium, so goes water. What happens with diuretics Decrease excess water

Olivia
Download Presentation

Drugs that affect the Urinary System

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Drugs that affect the Urinary System NURS 1950: Pharmacology

  2. Diuretics work in the kidney at various sites of the nephron • Can interfere with the action of aldosterone causing loss of sodium • Where goes sodium, so goes water

  3. What happens with diuretics • Decrease excess water • Loop diuretics + 0.9% NaCl = loss of calcium • Decrease excess NaCl • Decrease cerebral edema (Mannitol) • Decrease increased IOP (Diamox)

  4. Mannitol is an osmotic diuretic (a sugar); • in the brain, its presence causes water to be drawn to it • Works the same way in the eye: • the excess intraocular fluid is drawn to the mannitol in the hyperosmotic plasma

  5. Carbonic anhydrase inhibitor • Diamox very weak diuretic • Useful in treating glaucoma

  6. Methylxanthines • Aminophylline • Theophylline • Caffeine • Theobromine • Diuretic effect from improved blood flow to kidney • Generally not used for diuretic effect

  7. Obj. 9 Thiazides • Action of the thiazides • Act on the distal tubules of the kidney • Block reabsorption of sodium and chloride ions from the tubule • The unreabsorbed Na and Cl ions pass into the collecting ducts, taking water with them • Thiazides have antihypertensive properties because of direct vasodilation effect on peripheral arterioles • Expected outcomes from treatment • Decreased edema and improvement of symptoms RT excess fluid accumulation • Reduction in BP

  8. Thiazides • Assessments • Mental status • Diabetics require baseline blood glucose • Assess hearing • Assess for symptoms of acute gout • SE to expect: orthostatic hypotension • Usually in initial stages of treatment • Teach client safety measures

  9. Thiazides • SE to report • GI irritation, N/V, constipation • Electrolyte imbalance, dehydration • Hyperuricemia • Hyperglycemia • Hives, rash • Thiazides can interact with • Digoxin, corticosteroids • Lithium, NSAIDs • Oral hypoglycemic agents

  10. Thiazides can interact with • Digoxin, corticosteroids • Lithium, NSAIDs • Oral hypoglycemic agents

  11. Thiazide and Thiazide-like Drugs • Thiazide diuretics include • Bendroflumethiazide (Naturetin) • Chlorothiazide (Diuril) • Hydrochlorothiazide (HCTZ) {Esidrix, HydroDiuril} • Polythiazide (Renese) • Trichlomethiazide (Naqua, Metahydrin, Diurese)

  12. Thiazide-like drugs include • Chlorthalidone (Hygroton) • Indapamide (Lozol) • Metolazone (Zaroxolyn)

  13. Objective 8: describe the uses, actions, and adverse effects of the thiazide and thiazide-like diuretics • Drugs that affect the loop of Henle • Bumetanide (Bumex) • Ethacrynic acid (Edecrin) • Furosemide (Lasix) • Torsemide (Demadex)

  14. Loop Diuretics • Act in the loop of Henle in the kidney • Inhibits Na and Cl reabsorption • Some increase blood flow to glomeruli • Inhibits electrolyte absorption in proximal tubule • Lose sodium, chloride, potassium, magnesium, sodium bicarbonate

  15. Loop Diuretics • Onset of diuretic effect varies, but is within 1-2 hours. IV, drugs work within 5-10 minutes • Peak effect within 1-2 hours • Duration approximately 6 hours

  16. Loop Diuretics • Maximum mg/day • Bumex 10 mg per 24 hours • Edecrin 400 mg per 24 hours • Lasix 1000 mg/24 hours • Cross sensitivities • Sulfonamides and Lasix, Demadex • SE to expect • Oral irritation • Dry mouth • Orthostatic hypotension

  17. Loop Diuretics • SE to report with loop diuretics • GI irritation, abdominal pain • Electrolyte imbalance, dehydration • Hives, pruritus, rash • Some can cause loss of hearing and hyperglycemia (interfere with hypoglycemic agents)

  18. Loop Diuretics • Drug interactions • Alcohol, barbiturates, narcotics • Aminoglycosides • Cisplatin • NSAIDs • Corticosteroids • Probenecid • Digoxin

  19. Loop Diuretics • Loop diuretics include • Bumetanide (Bumex) • Ethacrynic acid (Edecrin) • Furosemide (Lasix) • Torsemide (Demadex)

  20. Objective 11: list the electrolyte imbalance that most commonly occurs as a result of diuretic therapy • Why is there concern about the electrolyte balance?

  21. Obj. 12 Potassium-Sparing Diuretics • Weak antihypertensives • Mechanism of action unknown • Do work in distal renal tubule • Retains potassium • Excretes sodium • Some have anti-aldosterone activity

  22. Potassium Sparing diuretics • Maximum dosing per 24 hrs • drug dependent • SE to expect with Midamor: • anorexia, N/V, flatulence and HA • SE to report: • electrolyte imbalance, dehydration,

  23. Potassium Sparing diuretics • SE to expect and report with Aldactone and Dyrenium: • mental confusion, HA, diarrhea, electrolyte imbalance, dehydration, gynecomastia, reduced libido, breast tenderness • Dyrenium can also cause allergic reaction (hives, pruritus, rash)

  24. Potassium Sparing diuretics • Generally, drug interactions for the K+ sparing agents • Lithium, ACE inhibitors, salt substitutes, K+ replacement • NSAIDs, • Potassium-sparing drugs include • Amiloride (Midamor) • Spironolactone (Aldactone) • Triamterene (Dyrenium)

  25. Potassium Sparing diuretics • Potassium-sparing drugs include • Amiloride (Midamor) • Spironolactone (Aldactone) • Triamterene (Dyrenium)

  26. Objective 13: explain how increased fluid intake enhances the action of diuretics • Why is an adequate fluid intake important with diuretic therapy? • If the client has to get up during the night to void, what will they probably do?

  27. Objective 14: list good dietary sources of potassium • What are some good dietary sources of potassium? • If a client is on Aldactone, what would you tell them about high potassium foods?

  28. Obj. 15Nursing Implications: Diuretics • Assessments to make • Teaching to include:

  29. Obj. 16 Drugs for UTI • Drugs include • Antibiotics • Fosfomycin (Monurol) • Quinolones : cinoxacin, nalidixic acid, norfloxacin • Methenamine madelate • Nitrofurantoin

  30. Fosfomycin (Monurol) • Inhibits bacterial cell wall synthesis • Reduces adherence of bacteria to epithelial cells of urinary tract • Single dose therapy • SE to expect: • nausea, diarrhea, abdominal cramps, flatulence • SE to report: • perineal burning, dysuria • Indicates UTI is not responding to treatment • Drug interactions • Drugs such as metoclopramide that increase GI motility

  31. Quinolones Norfloxacin (Noroxin) has wide range of activity against gram negative and gram positive bacteria • Expensive • Reserve for resistant/recurrent infections • SE to report • Hematuria as crystals can form in urinary tract • HA, tinnitus, dizziness, tingling sensations, photophobia • Various drug interactions can occur • Assess client’s current drug therapy, monograph of quinolone being used

  32. Methenamine mandelate (Mandelamine) • Converts to ammonia and formaldehyde in acidic urine • Used in clients susceptible to chronic, recurrent UTIs • Preexisting infections treated with antibiotics • Implementation • DO NOT crush the tablets • pH testing of urine: report over 5.5 • SE to expect • N/V, belching • SE to report • Hives, pruritus, rash • Bladder irritation, dysuria, frequency • Drug interactions • Acetazolamide, sodium bicarbonate • Sulfamethizole

  33. Nitrofurantoin (Furadantin, Macrodantin) • Interferes with several bacterial enzyme systems • Effective only in the urinary tract • SE to expect: • N/V, anorexia, urine discoloration • SE to report: • Dyspnea, chills, fever, erythematous rash, pruritus • Peripheral neuropathies • Second infection • Drug interactions • Magnesium containing products can decrease absorption

  34. Obj. 17 Bladder Active Drugs • Bethanecole chloride (Urecholine) • Neostigmine (Prostigmin) • Oxybutynin chloride (Ditropan) • Phenazopyridine (Pyridium) • Tolterodine (Detrol)

  35. Urecholine • Parasympathetic nerve stimulant • Causes contraction of detrusor urinae muscle • Results in urination • May also stimulate gastric motility • Can increase gastric tone • Can restore impaired rhythmic peristalsis • SE to expect • Flushing of skin, HA • SE to report • N/V, sweating, colicky pain, abdominal cramps • Diarrhea, belching, involuntary defecation

  36. Neostigmine (Prostigmin) • Anticholinesterase agent • Binds to cholinesterase • Prevents destruction of acetylcholine • Effects are: miosis; increased tone of intestinal, skeletal, and bladder muscles • Bradycardia; stimulation of secretions of salivary and sweat glands • Constriction of bronchi and ureters • Neostigmine used to prevent and treat postoperative distension and urinary retention • Assess for pregnancy, intestinal or urinary obstruction, peritonitis • Assess coronary status

  37. Oxybutynin (Ditropan) • Antispasmodic agent—acts directly on smooth muscle of the bladder • Delays initial urge to void • Do not use if glaucoma, myasthenia gravis, ulcerative colitis, obstructive uropathy • SE to expect • Dry mouth, urinary hesitance, retention • Constipation, bloating • Blurred vision • Report any SE that are intensified

  38. Phenazopyridine (Pyridium) • Produces local anesthetic effect in urinary tract • Acts about 30 min. after administration • Used to relieve burning, pain, urgency, frequency in UTI • Reduces bladder spasms • SE to expect • Reddish-orange urine color • SE to report • Yellow sclera or skin

  39. Tolterodine (Detrol) • Muscarinic receptor antagonists • Inhibit muscarinic action of acetylcholine on bladder smooth muscle • Used to treat overactive bladder • Do not use if glaucoma, ulcerative colitis, obstructive uropathy • S/E to expect • Dry mouth • Urinary hesitance, retention • Constipation, bloating • Blurred vision • Report if the effects intensified

  40. Objective 18: Discuss patient education guidelines for drugs that affect the urinary system

  41. Objective 19: identify at least one nursing diagnosis that may be applicable for clients receiving diuretic therapy under the guidance of the instructor

More Related